AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,334,000 | +18.3% | 87,132 | +7.9% | 0.13% | +18.5% |
| Q1 2022 | $1,128,000 | +1609.1% | 80,750 | +100.9% | 0.11% | +1700.0% |
| Q4 2021 | $66,000 | -84.4% | 40,200 | -71.3% | 0.01% | -72.7% |
| Q2 2021 | $424,000 | +100.9% | 140,151 | +209.4% | 0.02% | +57.1% |
| Q1 2021 | $211,000 | +137.1% | 45,300 | +126.5% | 0.01% | +75.0% |
| Q4 2020 | $89,000 | +107.0% | 20,000 | +100.0% | 0.01% | +100.0% |
| Q4 2019 | $43,000 | -95.9% | 10,000 | -85.5% | 0.00% | -98.5% |
| Q3 2019 | $1,042,000 | – | 69,052 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |